Stem Cell Therapy for Brain Development in Craniosynostosis
MSC implantation as a treatment for developmental brain defects in craniosynostosis
This project explores how implanting special stem cells might improve brain development and reduce pressure inside the head for children born with craniosynostosis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11096013 on NIH RePORTER |
What this research studies
Craniosynostosis is a condition where a baby's skull bones fuse too early, which can sometimes lead to brain development problems and increased pressure inside the head. We are looking into why these brain issues occur and how they relate to a loss of specific stem cells in the skull. Our approach involves implanting new stem cells to help the skull develop properly and reduce this pressure, with the hope of improving brain function. This work builds on promising earlier findings in animal models that showed success in restoring brain health.
Who could benefit from this research
Good fit: This research is relevant for children diagnosed with craniosynostosis, especially those who experience or are at risk for neurological deficits and increased intracranial pressure.
Not a fit: Patients without craniosynostosis or those whose condition does not involve developmental brain defects or elevated intracranial pressure would likely not benefit from this specific approach.
Why it matters
Potential benefit: If successful, this approach could offer a new way to prevent or reverse brain development problems and reduce intracranial pressure in children with craniosynostosis, potentially improving their long-term neurological outcomes.
How similar studies have performed: Previous animal studies have shown success in rescuing brain structure and function defects using a similar stem cell approach in a model of craniosynostosis, indicating a promising foundation for this novel strategy.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Chen, Jianfu — University of Southern California
- Study coordinator: Chen, Jianfu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.